Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clostridium butyricum for Prevention of Colorectal Adenoma Recurrence
NCT07167342Phase 4Recruiting
- Sponsor
- The Affiliated Hospital of Qingdao University
- Start
- May 2026
- Primary completion
- Apr 2030
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 4 trial of clostridium butyricum in Colorectal Adenoma (CRA), sponsored by The Affiliated Hospital of Qingdao University. Started May 2026; status: recruiting.
02
Drugs
clostridium butyricum
03
Conditions
Colorectal Adenoma (CRA)
Beyond the preview
Go deeper on NCT07167342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07167342.